-
CLINICAL AND ECONOMIC OUTCOMES OF WHOLE-BODY MRI SCREENING: A US EMPLOYER PERSPECTIVE
Aug 11, 2026, 17:16 PM -
DIGITAL THERAPEUTICS WORLDWIDE: A SCOPING REVIEW OF ADOPTION, REGULATION, REIMBURSEMENT/HTA, AND PATIENT OUTCOMES
Aug 11, 2026, 17:16 PM -
BALANCE TRAINING ON A STABILOMETRIC PLATFORM FOR TEAM ATHLETES
Aug 11, 2026, 17:16 PM -
TURNING HTA OUTCOMES INTO RELEVANT METRICS FOR SUBNATIONAL COMMISSIONING. A COPD POPULATION IMPACT MODEL FOR IMPLEMENTING NICE TA1142 AT THE LOCAL LEVEL
Aug 11, 2026, 17:16 PM -
BUDGET IMPACT AND CARBON CONSEQUENCES OF WEARABLE CARDIOVERTER-DEFIBRILLATOR USE IN FRANCE: A TWO-COHORT ANALYSIS OF POST-AMI/ISCHEMIC HEART FAILURE AND ICD EXPLANTATION
Aug 11, 2026, 17:16 PM -
THE INCIDENCE AND PREVALENCE OF ACNE VULGARIS IN THE UNITED KINGDOM: A POPULATION-BASED ELECTRONIC HEALTH RECORD STUDY (2004-2024)
Aug 11, 2026, 17:16 PM -
COST CONSEQUENCES ANALYSIS OF OCCUPATIONAL ACCIDENT: BALANCING FEE-FOR-SERVICE MODELS WITH COST CONTAINMENT STRATEGIES
Aug 11, 2026, 17:16 PM -
COST-UTILITY ANALYSIS OF ERIBULIN VERSUS DACARBAZINE IN ADVANCED LIPOSARCOMA IN INDIA: A MARKOV MODEL-BASED ECONOMIC EVALUATION
Aug 11, 2026, 17:16 PM -
BUDGET IMPACT ANALYSIS OF SINGLE-INHALER TRIPLE THERAPY (SITT) OF BUDESONIDE / GLYCOPYRRONIUM / FORMOTEROL FUMARATE DIHYDRATE FOR MODERATE TO VERY SEVERE PATIENTS WITH COPD IN ARGENTINA
Aug 11, 2026, 17:16 PM -
PREVALENCE AND INCIDENCE OF ADULTS WITH SEVERE HYPERTRIGLYCERIDAEMIA AND HIGH RISK OF ACUTE PANCREATITIS (>880 MG/DL): A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS
Aug 11, 2026, 17:16 PM -
REVIEW OF NICE SUBMISSIONS AND COMPARISON OF ECONOMIC MODEL STRUCTURES AND METHODOLOGICAL PRECEDENT IN RETINAL DISEASES
Aug 11, 2026, 17:16 PM -
COMPARING EU JOINT CLINICAL ASSESSMENT AND US FDA EVIDENCE REQUIREMENTS IN ONCOLOGY: A CROSS-JURISDICTIONAL FRAMEWORK USING TOVORAFENIB AS A PILOT CASE
Aug 11, 2026, 17:16 PM -
EPIDEMIOLOGY AND TREATMENT PATHWAYS OF SCHIZOPHRENIA IN ENGLAND
Aug 11, 2026, 17:16 PM -
FROM SPEED TO CERTAINTY: FEE STRUCTURES, SME INCENTIVES AND PERFORMANCE CRITERIA SHAPING ACCESS TIME IN A COMPARATIVE LANDSCAPE OF GLOBAL REGULATORS
Aug 11, 2026, 17:16 PM -
CLINICAL AND ECONOMIC IMPACT OF CYP2C19 GENOTYPE-GUIDED ANTIPLATELET THERAPY IN STEMI PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A SIMULATION-BASED ANALYSIS
Aug 11, 2026, 17:16 PM -
MORE THAN DOUBLING OF COSTS WITH UNCHANGED 12-MONTH MORTALITY IN INCIDENT METASTATIC PROSTATE CANCER IN GERMANY, 2011-2024
Aug 11, 2026, 17:16 PM -
BEYOND THE BIOMARKER: HTA CHALLENGES FOR PRECISION ONCOLOGY TECHNOLOGIES IN NICE APPRAISALS
Aug 11, 2026, 17:16 PM -
HEALTH TECHNOLOGY ASSESSMENT (HTA) AND HEALTHCARE EQUITY IN THE MIDDLE EAST AND NORTH AFRICA (MENA) REGION: A MULTI-COUNTRY QUALITATIVE ANALYSIS OF STAKEHOLDER PERSPECTIVES
Aug 11, 2026, 17:16 PM -
FROM STRUCTURAL TO PARAMETER UNCERTAINTY: EVIDENCE OF REFERENCE MODEL MATURITY IN DUCHENNE MUSCULAR DYSTROPHY HEALTH TECHNOLOGY ASSESSMENTS
Aug 11, 2026, 17:16 PM -
A GENERALIZED MODELING FRAMEWORK FOR THE INDIRECT ESTIMATION OF HOSPITALIZATIONS ATTRIBUTABLE TO SPECIFIC RESPIRATORY VIRUSES INCORPORATING MULTI-PATHOGEN DYNAMICS AND PANDEMIC-DISRUPTED STUDY PERIODS
Aug 11, 2026, 17:16 PM
